In a significant development in women’s health, the The Endocrine Society has proposed renaming Polycystic Ovary Syndrome to Polyendocrine Metabolic Ovarian Syndrome (PMOS). The move aims to better reflect the complex hormonal and metabolic nature of the condition and improve diagnosis and treatment outcomes.
Why the Name Change Matters
According to a study published in The Lancet, the term PCOS is misleading as it focuses on ovarian cysts, which are not always present. Experts argue that this narrow definition often leads to delayed diagnosis and contributes to stigma.
The new name, PMOS, captures the broader spectrum of endocrine, metabolic, and reproductive dysfunctions associated with the condition, offering a more accurate clinical understanding.
A Widespread Yet Underdiagnosed Condition
PCOS affects an estimated 170 million women worldwide during their reproductive years. Diagnosis typically requires at least two of the following:
- Irregular or absent ovulation
- Elevated male hormone levels (hyperandrogenism)
- Polycystic ovaries detected via ultrasound or hormone levels
However, studies suggest that up to 70% of cases remain undiagnosed, largely due to limited awareness and inconsistent diagnostic approaches.
FutureCrime Summit 2026: Registrations to Open Soon for India’s Biggest Cybercrime Conference
Beyond Reproductive Health
Experts emphasize that the condition is not just gynecological but multi-dimensional. It includes:
- Metabolic issues: obesity, type 2 diabetes, hypertension
- Reproductive concerns: irregular periods, infertility, pregnancy complications
- Psychological effects: anxiety, depression, eating disorders
- Dermatological symptoms: acne, hair loss, excess hair growth
The new classification aims to encompass all these aspects, improving holistic care.
Driving the Change
The renaming initiative was led by Professor Helena J. Teede of Monash University, along with over 50 global medical and patient organizations.
Experts believe the change will:
- Reduce stigma linked to fertility-focused terminology
- Improve early diagnosis and awareness
- Encourage better treatment strategies
- Align global medical guidelines
A phased global implementation, including education and healthcare system alignment, is currently underway.
